CO

Core Scientific, Inc.

CORZTechnologyNASDAQ

Software - Infrastructure · Last scanned Sep 5, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$319.0M
-37.5% YoY
Net Income
-$288.6M
+79.9% YoY
EBITDA
-$144.4M
+88.7% YoY
Free Cash Flow
$464.8M

Scan Results

Daily timeframe
2 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Sep 3 RSI OversoldRSI 29.3, below 30, stock may be oversold
Sep 2 RSI OversoldRSI 18.1, below 30, stock may be oversold
About Core Scientific, Inc.

Core Scientific, Inc. provides infrastructure for high-density colocation services and digital asset mining in the United States. At a $5.75B market cap, Core Scientific, Inc. ranks as a mid-cap company within technology. It operates through three segments: Colocation, Digital Asset Self-Mining, and Digital Asset Hosted Mining.

Where CORZ stands vs its 150-day and 200-day moving averages

As of the September 3, 2026 close, CORZ finished 18.83% below its 150-day moving average ($20.71) and 14.50% below its 200-day moving average ($19.66). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is CORZ overbought or oversold?

At the September 3, 2026 close, CORZ's RSI(14) was 29.3, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$5.75B
Fwd P/E127.79
EPS$-5.04
Beta5.49
52W Change+28.5%
Analysis

On the balance sheet, CORZ has $1.77B in cash with $4.41B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $464.8M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Revenue has pulled back from $640.3M (2022) to $319.0M (2025), a 50% decline worth watching.

With a beta above 1.5, CORZ tends to amplify broader market moves — both up and down. This higher volatility means larger price swings are common. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Core Scientific, Inc.'s trajectory.

Links
More Technology stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms